Altaris Acquires Clarivate’s Life Sciences & Healthcare Segment

Altaris Acquires Clarivate Life Sciences & Healthcare Segment

October 6, 2026

Data & Analytics

Altaris acquired Clarivate’s Life Sciences & Healthcare segment for $600 million. Clarivate said the completed divestiture advances its strategic transformation, simplifies its portfolio, and provides proceeds to reduce debt and strengthen its balance sheet.

1315 Capital Acquires Argonaut’s Life Sciences and Diagnostics Division as Aluris Sciences

September 14, 2026

Manufacturing

1315 Capital acquired Argonaut Manufacturing Services’ Life Sciences and Diagnostics division, which now operates independently as Aluris Sciences. The completed carve-out allows Argonaut to reinvest the sale proceeds in its core injectable fill-finish operations, while Aluris gains focused ownership and resources to expand its contract manufacturing capabilities.

Altaris Acquires Tegria Services Group from Providence St. Joseph Health

January 6, 2026

Healthcare Services

Altaris has completed the acquisition of Tegria Services Group, Inc. from Providence St. Joseph Health, establishing Tegria as a standalone, Altaris‑backed portfolio company that will continue to serve Providence as a preferred technology services partner. The deal positions Altaris to expand its healthcare services and technology platform capabilities—supporting providers and payers with consulting, managed services, data & analytics, and revenue cycle management.

Altaris Acquires Sharecare

June 25, 2024

Healthcare Services

Altaris, a healthcare-focused investment firm, agreed to acquire publicly traded digital health company Sharecare in a take-private transaction at $1.43 per share. The deal will take Sharecare private (stockholders approved the transaction) and positions the company to operate as a standalone portfolio company under Altaris to accelerate growth and product/service development.

Altaris Capital Partners Acquires Meridian Medical Technologies from Pfizer

December 30, 2021

Medical Devices

Altaris Capital Partners has entered into an agreement to acquire Meridian Medical Technologies from Pfizer. Meridian, a pioneer in emergency response drug-device combination products and auto-injectors with facilities in St. Louis, Missouri and Columbia, Maryland and more than 750 employees, will become an Altaris portfolio company to expand the firm's capabilities in medical countermeasures and emergency response solutions.

Symantec Corporation Acquires Altiris Inc. for $830M

January 29, 2017

Software

Symantec Corporation agreed to acquire Altiris Inc. for approximately $830 million in cash ($33 per share) to expand its presence in the corporate software market. The deal, announced by Symantec, is expected to close in the second quarter pending regulatory and shareholder approvals and is intended to strengthen Symantec's enterprise management and IT asset-management capabilities.